Lastly, in regard to the immunopotentiation approach, HER2/neu, a protein shown to be overexpressed in ovarian cancer [79], was delivered to dendritic cells (DCs) by an AAV and primed these cells to express a self-tumour antigen. This evidence concerns the gene ERBB2 and ovarian cancer.